{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:30:20Z","timestamp":1781058620176,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:00:00Z","timestamp":1633132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:00:00Z","timestamp":1633132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["2011FoBi0399"],"award-info":[{"award-number":["2011FoBi0399"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["2013fobi37677"],"award-info":[{"award-number":["2013fobi37677"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s11033-021-06721-2","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T12:45:50Z","timestamp":1633351550000},"page":"7621-7626","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ribonucleotide reductase: In-vitro S-glutathionylation of R2 and p53R2 subunits of mammalian class I ribonucleotide reductase protein"],"prefix":"10.1007","volume":"48","author":[{"given":"Ajanta","family":"Chatterji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Holmgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9665-8784","authenticated-orcid":false,"given":"Rajib","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,2]]},"reference":[{"issue":"21","key":"6721_CR1","doi-asserted-by":"publisher","first-page":"12249","DOI":"10.1016\/S0021-9258(18)63849-9","volume":"264","author":"A Aberg","year":"1989","unstructured":"Aberg A, Hahne S, Karlsson M, Larsson A, Orm\u00f6 M, Ahgren A, Sj\u00f6berg BM (1989) Evidence for two different classes of redox-active cysteines in ribonucleotide reductase of Escherichia coli. J Biol Chem 264(21):12249\u201312252","journal-title":"J Biol Chem"},{"key":"6721_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1146\/annurev.biochem.75.103004.142443","volume":"75","author":"P Nordlund","year":"2006","unstructured":"Nordlund P, Reichard P (2006) Ribonucleotide reductases. Annu Rev Biochem 75:681\u2013706. https:\/\/doi.org\/10.1146\/annurev.biochem.75.103004.142443","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"6721_CR3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/ng0607-703","volume":"39","author":"L Thelander","year":"2007","unstructured":"Thelander L (2007) Ribonucleotide reductase and mitochondrial DNA synthesis. Nat Genet 39(6):703\u2013704. https:\/\/doi.org\/10.1038\/ng0607-703","journal-title":"Nat Genet"},{"issue":"2","key":"6721_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.molcel.2017.03.005","volume":"66","author":"IP Foskolou","year":"2017","unstructured":"Foskolou IP, Jorgensen C, Leszczynska KB, Olcina MM, Tarhonskaya H, Haisma B, D\u2019Angiolella V, Myers WK, Domene C, Flashman E, Hammond EM (2017) Ribonucleotide reductase requires subunit switching in hypoxia to maintain DNA replication. Mol Cell 66(2):206-220.e9. https:\/\/doi.org\/10.1016\/j.molcel.2017.03.005","journal-title":"Mol Cell"},{"issue":"11","key":"6721_CR5","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.freeradbiomed.2010.09.005","volume":"49","author":"A Holmgren","year":"2010","unstructured":"Holmgren A, Sengupta R (2010) The use of thiols by ribonucleotide reductase. Free Radic Biol Med 49(11):1617\u20131628. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.09.005","journal-title":"Free Radic Biol Med"},{"issue":"5-6","key":"6721_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1089\/ars.2006.8.735","volume":"8","author":"S Gon","year":"2006","unstructured":"Gon S, Faulkner MJ, Beckwith J (2006) In vivo requirement for glutaredoxins and thioredoxins in the reduction of the ribonucleotide reductases of Escherichia coli. Antioxid Redox Signal 8(5\u20136):735\u2013742. https:\/\/doi.org\/10.1089\/ars.2006.8.735","journal-title":"Antioxid Redox Signal"},{"issue":"13","key":"6721_CR7","doi-asserted-by":"publisher","first-page":"8233","DOI":"10.1074\/jbc.M809338200","volume":"284","author":"F Zahedi Avval","year":"2009","unstructured":"Zahedi Avval F, Holmgren A (2009) Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for Mammalian s phase ribonucleotide reductase. J Biol Chem 284(13):8233\u20138240. https:\/\/doi.org\/10.1074\/jbc.M809338200","journal-title":"J Biol Chem"},{"issue":"34","key":"6721_CR8","doi-asserted-by":"publisher","first-page":"12708","DOI":"10.1074\/jbc.RA119.008752","volume":"294","author":"R Sengupta","year":"2019","unstructured":"Sengupta R, Coppo L, Mishra P, Holmgren A (2019) Glutathione\u2013glutaredoxin is an efficient electron donor system for mammalian p53R2-R1-dependent ribonucleotide reductase. J Biol Chem 294(34):12708\u201312716. https:\/\/doi.org\/10.1074\/jbc.RA119.008752","journal-title":"J Biol Chem"},{"issue":"6490","key":"6721_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/370533a0","volume":"370","author":"U Uhlin","year":"1994","unstructured":"Uhlin U, Eklund H (1994) Structure of ribonucleotide reductase protein R1. Nature 370(6490):533\u2013539. https:\/\/doi.org\/10.1038\/370533a0","journal-title":"Nature"},{"issue":"7","key":"6721_CR10","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1083\/jcb.201804161","volume":"217","author":"A Bansal","year":"2018","unstructured":"Bansal A, Simon MC (2018) Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol 217(7):2291\u20132298. https:\/\/doi.org\/10.1083\/jcb.201804161","journal-title":"J Cell Biol"},{"key":"6721_CR11","doi-asserted-by":"publisher","first-page":"108890","DOI":"10.1016\/j.abb.2021.108890","volume":"704","author":"D Pal","year":"2021","unstructured":"Pal D, Rai A, Checker R, Patwardhan RS, Singh B, Sharma D, Sandur SK (2021) Role of protein S-glutathionylation in cancer progression and development of resistance to anti-cancer drugs. Arch Biochem Biophys 704:108890. https:\/\/doi.org\/10.1016\/j.abb.2021.108890","journal-title":"Arch Biochem Biophys"},{"issue":"7","key":"6721_CR12","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1021\/bi00221a030","volume":"30","author":"GJ Mann","year":"1991","unstructured":"Mann GJ, Gr\u00e4slund A, Ochiai E, Ingemarson R, Thelander L (1991) Purification and characterization of recombinant mouse and herpes simplex virus ribonucleotide reductase R2 subunit. Biochemistry 30(7):1939\u20131947. https:\/\/doi.org\/10.1021\/bi00221a030","journal-title":"Biochemistry"},{"issue":"44","key":"6721_CR13","doi-asserted-by":"publisher","first-page":"40647","DOI":"10.1074\/jbc.M106088200","volume":"276","author":"O Guittet","year":"2001","unstructured":"Guittet O, H\u00e5kansson P, Voevodskaya N, Fridd S, Gr\u00e4slund A, Arakawa H, Nakamura Y, Thelander L (2001) Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells. J Biol Chem 276(44):40647\u201340651. https:\/\/doi.org\/10.1074\/jbc.M106088200","journal-title":"J Biol Chem"},{"issue":"37","key":"6721_CR14","doi-asserted-by":"publisher","first-page":"23171","DOI":"10.1016\/S0021-9258(17)31635-6","volume":"269","author":"R Davis","year":"1994","unstructured":"Davis R, Thelander M, Mann GJ, Behravan G, Soucy F, Beaulieu P, Lavall\u00e9e P, Gr\u00e4slund A, Thelander L (1994) Purification, characterization, and localization of subunit interaction area of recombinant mouse ribonucleotide reductase R1 subunit. J Biol Chem 269(37):23171\u201323176","journal-title":"J Biol Chem"},{"issue":"28","key":"6721_CR15","doi-asserted-by":"publisher","first-page":"26269","DOI":"10.1074\/jbc.M011605200","volume":"276","author":"M Lundberg","year":"2001","unstructured":"Lundberg M, Johansson C, Chandra J, Enoksson M, Jacobsson G, Ljung J, Johansson M, Holmgren A (2001) Cloning and expression of a novel human glutaredoxin (Grx2) with mitochondrial and nuclear isoforms. J Biol Chem 276(28):26269\u201326275. https:\/\/doi.org\/10.1074\/jbc.M011605200","journal-title":"J Biol Chem"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06721-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06721-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06721-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T17:07:20Z","timestamp":1636304840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06721-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,2]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["6721"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06721-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,2]]},"assertion":[{"value":"17 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}